Cambridge Trust’s Elevance Health ELV Stock Holding History

Cambridge Trust’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$28K	Sell	54 -30	-36%	-$14.9K	﹤0.01%	486
2023 Q4	$39.6K	Sell	84 -25	-23%	-$11.6K	﹤0.01%	444
2023 Q3	$47.5K	Sell	109 -75	-41%	-$34K	﹤0.01%	419
2023 Q2	$81.7K	Hold	184	–	–	﹤0.01%	376
2023 Q1	$84.6K	Buy	184 +61	+50%	+$29K	﹤0.01%	377
2022 Q4	$63K	Sell	123 -10	-8%	-$5.08K	﹤0.01%	427
2022 Q3	$60K	Buy	133 +41	+45%	+$19.6K	﹤0.01%	428
2022 Q2	$45K	Sell	92 -23	-20%	-$11.4K	﹤0.01%	493
2022 Q1	$56K	Sell	115 -149	-56%	-$68.1K	﹤0.01%	516
2021 Q4	$122K	Buy	+264	New	+$111K	﹤0.01%	399

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cambridge Trust's ELV Position: Q1 2024 in Review

Cambridge Trust reduced its Elevance Health (ELV) stake by 36% in Q1 2024, selling an estimated $14.9K and leaving 54 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #486.

Cambridge Trust first reported a position in ELV in Q4 2021 and has held it in 10 quarters since. The position peaked at $122K in Q4 2021. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

Cambridge Trust held 54 shares of Elevance Health worth $28K as of Q1 2024.
Cambridge Trust sold 30 Elevance Health shares in Q1 2024, an estimated $14.9K.
Elevance Health made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #486 holding.
Cambridge Trust first reported a position in Elevance Health in Q4 2021 and has held it in 10 quarters since.
Cambridge Trust's Elevance Health position peaked at $122K in Q4 2021.
1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.